Collagen mimetic and method of treating rheumatoid arthritis using same
AssigneeA. Glenn Braswell
InventorsA. Glenn Braswell, Aftab J. Ahmed
Life of this patent
Estimating the term…
Abstract
A collagen mimetic peptide having the nine amino acid sequence glycine-proline-hydroxyproline-glycine -proline-glutamine-glycine-methionine-glycine, and analogs thereof is described. The collagen mimetic peptide may be included within a pharmaceutical composition also containing a pharmaceutically acceptable carrier and/or animal tissue. The collagen mimetic peptide is used in a treatment of rheumatoid arthritis by orally administering the collagen mimetic in an amount effective to reduce or alleviate one or more symptoms associated with rheumatoid arthritis.
Claims19
A collagen mimetic peptide consisting of the nine amino acid sequence glycine-proline-hydroxyproline -glycine-proline-glutamine-glycine-methionine -glycine or analogs thereof.
A composition, the composition comprising a collagen mimetic peptide having the nine amino acid sequence glycine-proline -hydroxyproline-glycine-proline-glutamine-glycine-methionine-glycine or analogs thereof, wherein the composition contains from 0.01 to 10 mg of the collagen mimetic peptide.
A method of treating rheumatoid arthritis, the method comprising orally administering a collagen mimetic peptide having the nine amino acid sequence glycine -proline-hydroxyproline-glycine-proline-glutamine-glycine-methionine-glyci ne or analogs thereof in an amount effective to reduce or alleviate at least one symptom associated with rheumatoid arthritis, wherein the collagen mimetic peptide is administered in a total daily amount of from 0.01 to 10 mg.
Dependencies are inferred from the claim text.